Showing results (101-110 of 110) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2019
Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary SiteHidetoshi Hayashi, Takayasu Kurata, Yuichi Takiguchi, et al.Clinical Colorectal Cancer|September 28, 2016
Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective ComparisonToshiki Masuishi, Hiroya Taniguchi, Satoshi Hamauchi, et al.Oncology|September 4, 2017
Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal CancerAzusa Komori, Hiroya Taniguchi, Satoshi Hamauchi, et al.Clinical Colorectal Cancer|August 15, 2016
Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102Satoshi Hamauchi, Kentaro Yamazaki, Toshiki Masuishi, et al.International Journal of Clinical Oncology|March 27, 2015
Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancerMasahiro Nozawa, Hirofumi Mukai, Shunji Takahashi, et al.Anticancer Research|August 30, 2022
Immunological and Genetic Characterization of Patients With Head and Neck Cancer who Developed RecurrenceKazuaki Yasui, Ryota Kondou, Haruo Miyata, et al.International Journal of Clinical Oncology|June 18, 2015
Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summaryHideki Takeuchi, Toshiaki Saeki, Keisuke Aiba, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2022
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled TrialNaomi Kiyota, Makoto Tahara, Junki Mizusawa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2026
Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck CancerMakoto Tahara, Naomi Kiyota, Takeshi Kodaira, et al.Oral Oncology|August 7, 2024
Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008Hidetoshi Shimizu, Takeshi Kodaira, Naomi Kiyota, et al.Pageof 11